Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
114 EUR | +0.13% | -.--% | -.--% |
May. 07 | Dsm-Firmenich Ag Approves Retirement of Pradeep Pant from the Board | CI |
May. 07 | Dsm-Firmenich Ag Approves the Dividend, Payable May 16, 2024 | CI |
Sales 2024 * | 12.64B 13.68B | Sales 2025 * | 13.31B 14.41B | Capitalization | 28.72B 31.1B |
---|---|---|---|---|---|
Net income 2024 * | 444M 481M | Net income 2025 * | 789M 854M | EV / Sales 2024 * | 2.5 x |
Net Debt 2024 * | 2.86B 3.09B | Net Debt 2025 * | 2.59B 2.81B | EV / Sales 2025 * | 2.35 x |
P/E ratio 2024 * |
63.5
x | P/E ratio 2025 * |
36.7
x | Employees | 28,685 |
Yield 2024 * |
2.32% | Yield 2025 * |
2.28% | Free-Float | 25.03% |
Latest transcript on Koninklijke DSM
1 day | +0.13% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 89-12-31 | |
Ralf Schmeitz
DFI | Director of Finance/CFO | - | 23-08-31 |
Sarah Reisinger
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 23-01-31 | |
Thomas Leysen
CHM | Chairman | 63 | 23-01-31 |
Director/Board Member | 62 | 23-01-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.43% | 304 M€ | +16.76% | ||
1.13% | 17 M€ | +8.38% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.20% | 895B | |
0.00% | 239B | |
+26.00% | 176B | |
-3.30% | 133B | |
+47.74% | 88.64B | |
-5.04% | 74.24B | |
-7.16% | 57.07B | |
+40.05% | 37.69B | |
-32.34% | 35.66B |
- Stock Market
- Equities
- DSFIR Stock
- DSM Stock